Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metastatic Progression of Human Melanoma. | Cancers (Basel) | 2023 | 36831566 | PubTator, text mining | PubMed |
| Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers. | Biomolecules | 2023 | 36830628 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. | Noncoding RNA | 2023 | 36827542 | PubTator, text mining | PubMed |
| High dose isoleucine stabilizes nuclear PTEN to suppress the proliferation of lung cancer. | Discov Oncol | 2023 | 36820928 | PubTator, text mining | PubMed |
| Editorial: Ubiquitin and ubiquitin-like modifications in viral infection and innate immunity. | Front Immunol | 2023 | 36817466 | PubTator, text mining | PubMed |
| Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. | Prostaglandins Other Lipid Mediat | 2023 | 36813255 | PubTator, text mining | PubMed |
| Development of a robust HTRF assay with USP7 full length protein expressed in E. coli prokaryotic system for the identification of USP7 inhibitors. | J Pharm Biomed Anal | 2023 | 36812797 | PubTator, text mining | PubMed |
| Ubiquitin specific peptidases and prostate cancer. | PeerJ | 2023 | 36811009 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators to overcome drug resistance in cancers. | Signal Transduct Target Ther | 2023 | 36797239 | PubTator, text mining | PubMed |
| USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signaling. | Biochim Biophys Acta Mol Cell Res | 2023 | 36791810 | PubTator, text mining | PubMed |
| Decoding the Role of MDM2 as a Potential Ubiquitin E3 Ligase and Identifying the Therapeutic Efficiency of Alkaloids against MDM2 in Combating Glioblastoma. | ACS Omega | 2023 | 36777618 | PubTator, text mining | PubMed |
| Systematic identification of factors involved in the silencing of germline genes in mouse embryonic stem cells. | Nucleic Acids Res | 2023 | 36772830 | PubTator, text mining | PubMed |
| Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 0 (ICP0) Targets of Ubiquitination during Productive Infection of Primary Adult Sensory Neurons. | Int J Mol Sci | 2023 | 36769256 | PubTator, text mining | PubMed |
| Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma. | Int J Mol Sci | 2023 | 36768967 | PubTator, text mining | PubMed |
| The Role of TP53 in Adaptation and Evolution. | Cells | 2023 | 36766853 | PubTator, text mining | PubMed |
| TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance. | Cell Death Dis | 2023 | 36765039 | PubTator, text mining | PubMed |
| Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. | Cell Commun Signal | 2023 | 36759819 | PubTator, text mining | PubMed |
| Angiotensin-converting enzyme inhibitor promotes angiogenesis through Sp1/Sp3-mediated inhibition of notch signaling in male mice. | Nat Commun | 2023 | 36759621 | PubTator, text mining | PubMed |
| Spin column-based peptide fractionation alternatives for streamlined tandem mass tag (SL-TMT) sample processing. | J Proteomics | 2023 | 36758854 | PubTator, text mining | PubMed |
| Accelerating inhibitor discovery for deubiquitinating enzymes. | Nat Commun | 2023 | 36754960 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=38